232 related articles for article (PubMed ID: 18456002)
1. Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.
Liu F; Hindupur J; Nguyen JL; Ruf KJ; Zhu J; Schieler JL; Bonham CC; Wood KV; Davisson VJ; Rochet JC
Free Radic Biol Med; 2008 Aug; 45(3):242-55. PubMed ID: 18456002
[TBL] [Abstract][Full Text] [Related]
2. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms.
Wassef R; Haenold R; Hansel A; Brot N; Heinemann SH; Hoshi T
J Neurosci; 2007 Nov; 27(47):12808-16. PubMed ID: 18032652
[TBL] [Abstract][Full Text] [Related]
3. Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells.
Oien DB; Shinogle HE; Moore DS; Moskovitz J
J Mol Neurosci; 2009 Nov; 39(3):323-32. PubMed ID: 19653131
[TBL] [Abstract][Full Text] [Related]
4. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of methionine sulphoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in rat liver cells.
Vougier S; Mary J; Friguet B
Biochem J; 2003 Jul; 373(Pt 2):531-7. PubMed ID: 12693988
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
Höglinger GU; Carrard G; Michel PP; Medja F; Lombès A; Ruberg M; Friguet B; Hirsch EC
J Neurochem; 2003 Sep; 86(5):1297-307. PubMed ID: 12911637
[TBL] [Abstract][Full Text] [Related]
8. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
Zafar KS; Inayat-Hussain SH; Ross D
J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines.
Alvarez-Castelao B; Goethals M; Vandekerckhove J; Castaño JG
Biochim Biophys Acta; 2014 Feb; 1843(2):352-65. PubMed ID: 24315858
[TBL] [Abstract][Full Text] [Related]
12. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
Elkon H; Melamed E; Offen D
Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
[TBL] [Abstract][Full Text] [Related]
13. Methionine sulfoxide reductase A (MsrA) restores alpha-crystallin chaperone activity lost upon methionine oxidation.
Brennan LA; Lee W; Giblin FJ; David LL; Kantorow M
Biochim Biophys Acta; 2009 Dec; 1790(12):1665-72. PubMed ID: 19733220
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
[TBL] [Abstract][Full Text] [Related]
15. Methionine sulfoxide reductase A attenuates heme oxygenase-1 induction through inhibition of Nrf2 activation.
Kim JY; Choi SH; Lee E; Kang YJ; Kim HY
Arch Biochem Biophys; 2012 Dec; 528(2):134-40. PubMed ID: 23036869
[TBL] [Abstract][Full Text] [Related]
16. Modulation of alpha-synuclein aggregation by dopamine: a review.
Leong SL; Cappai R; Barnham KJ; Pham CL
Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
[TBL] [Abstract][Full Text] [Related]
18. The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease.
Michell AW; Tofaris GK; Gossage H; Tyers P; Spillantini MG; Barker RA
Cell Transplant; 2007; 16(5):461-74. PubMed ID: 17708336
[TBL] [Abstract][Full Text] [Related]
19. Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase.
Sun H; Gao J; Ferrington DA; Biesiada H; Williams TD; Squier TC
Biochemistry; 1999 Jan; 38(1):105-12. PubMed ID: 9890888
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization and regulation of mitochondrial function by methionine sulfoxide reductases in yeast.
Kaya A; Koc A; Lee BC; Fomenko DE; Rederstorff M; Krol A; Lescure A; Gladyshev VN
Biochemistry; 2010 Oct; 49(39):8618-25. PubMed ID: 20799725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
